Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-07-07FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium tablets from Aurobindo Pharma Limited (ANDA 090083). This is an approval of a…
-
FDA approval · 2015-06-09FDA Approved: VALSARTAN — Original Application (Solco Healthcare US, LLC)
FDA approved the original ANDA for valsartan (generic) submitted by Solco Healthcare US, LLC, authorizing marketing of this ARB for hyperten…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: VA NEPHRON-D: Diabetes iN Nephropathy Study [Phase 3]
A Phase 3 trial assessing dual RAAS blockade with losartan plus lisinopril in diabetic nephropathy was terminated early due to safety concer…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Minocycline and Proteinuria in Diabetic Nephropathy [NA]
This clinical trial update investigates minocycline for reducing proteinuria in diabetic nephropathy; current status information is not prov…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes [Phase 2]
This update covers a Phase 2b study of GCS-100 in patients with diabetic kidney disease, noting that the study status is currently UNKNOWN.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-04-21Clinical Trial Update: Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.
This clinical trial update concerns estimating glomerular filtration rate (GFR) in patients with type 2 diabetes mellitus, including those w…
-
FDA approval · 2015-04-10FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for Jubilant Cadista's Losartan Potassium Tablets, 25 mg, supporting the approval of this generic do…
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) [Phase 3]
Phase 3 trial DEMAND evaluating the combination of delapril and manidipine for nephroprotection in diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy [Phase 2]
A Phase 2 study of NCX4016 in patients with Type 2 diabetes and early nephropathy was terminated. No efficacy or safety results are provided…
-
FDA approval · 2015-03-31FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application to add a 25 mg strength of Losartan Potassium Tablets, expanding the product's dosage options. The a…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients [NA]
This completed clinical trial evaluated the effect of a low GI/low glycemic load diet on patients with diabetic nephropathy. The sponsor is …
-
FDA approval · 2015-02-23FDA Approved: IRBESARTAN — Original Application (AvKARE)
FDA approved AvKARE's original generic application for irbesartan (IRBESARTAN). Irbesartan is used to treat hypertension.
-
CLINICAL_TRIALS research · 2015-02-23Clinical Trial Update: Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
Clinical trial update examining the role of matrix metalloproteinases in atherosclerosis associated with chronic kidney disease in patients …
-
FDA approval · 2015-02-13FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for Losartan Potassium from Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. [Phase 3]
Phase 3 clinical trial evaluating the role of sleep apnea and sympathetic activity in patients with resistant hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR [Phase 2]
This Phase 2 trial update reports on pharmacodynamics, safety, tolerability, and pharmacokinetics of MT-3995 in patients with diabetic nephr…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria [Phase 2]
A Phase 2 study to evaluate pharmacodynamics, safety, tolerability and pharmacokinetics of MT-3995 in adults with type 2 diabetic nephropath…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy [Phase 1, Phase 2]
This clinical trial update summarizes a Phase 1/2 study of MT-3995 in diabetic nephropathy, focusing on safety, tolerability, and pharmacoki…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease) [Phase 3]
The PREVENTKD Phase 3 trial in type 1 diabetes mellitus was terminated and results were posted in January 2015.
-
FDA approval · 2015-01-05FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2014-12-11FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved a supplemental application for Losartan Potassium from Solco Healthcare US, LLC.
-
FDA approval · 2014-12-05FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for captopril from Hikma Pharmaceuticals USA, documenting changes to the marketed captopril product …
-
FDA approval · 2014-11-05FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)
FDA approves a supplemental application for losartan potassium from Micro Labs Limited.
-
FDA approval · 2014-11-04FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA has granted supplemental approval for Losartan Potassium from Macleods Pharmaceuticals Limited. This action approves the supplementa…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Pioglitazone and Losartan Provides Additional Renoprotection [NA]
A completed clinical trial evaluating pioglitazone plus losartan suggests additional renoprotective effects in patients with type 2 diabetes…